SCIENSUS PHARMA SERVICES LIMITED

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

1. SCIENSUS PHARMA SERVICES LIMITED 2022-04-20 → present
2. HEALTHCARE AT HOME LTD 1992-12-21 → 2022-04-20
3. HEALTH CARE AT HOME LIMITED 1992-10-28 → 1992-12-21

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“As a consequence, the Directors have a reasonable expectation that the Company is well placed to manage its business risks and to continue in operational existence for the foreseeable future. Accordingly, the Directors continue to adopt the going concern basis in preparing these Financial Statements.”

Group structure

1. SCIENSUS PHARMA SERVICES LIMITED · parent
   1. Sciensus International B.V. 100% · Netherlands · Pharmaceutical product supply chain
   2. Sciensus GmbH 100% · Germany · Provision of customer services
   3. Sciensus AG 100% · Switzerland · Provision of nursing services
   4. Sciensus Logistics Limited 100% · England · Provision of life science product services
   5. Vinehealth Digital Limited 100% · England · Software development
   6. Medihome Limited 100% · England · Dormant company
   7. Sciensus Limited 100% · England · Dormant company
   8. Healthcare at Home Limited 100% · England · Dormant company
   9. Sciensus Apotheke AG 100% · Switzerland · Medical supply chain (Pharmacy)
   10. Sciensus Wholesale AG 100% · Switzerland · Wholesale of pharmaceuticals

Significant events

• “The year to 31 March 2025 has been another period of significant progress for the business as we continue to invest in sector-leading digital technology.”
• “Operating profit before adjusted items was £8.9m (2024: £14.8m), a decrease of 40%. This is expected to improve in coming years as the impacts of restructuring projects come to fruition.”
• “The Company continues on its business transformation journey. Enhanced quality controls within the Compounding unit processes were designed and implemented. Furthermore, costs relating to the external review and restructuring activities associated to the ongoing operational efficiency projects... contributed to the overall transformation costs.”
• “Cost of investment in Vinehealth Digital Limited was impaired by £1,005,000 in the year (2024: £nil) following transfer of that business to the Company.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

9

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -3.6%

  £1,659,600,000 → £1,599,232,000

• Cash

  +6.5%

  £1,047,000 → £1,115,000

• Net assets

  -19.5%

  £53,693,000 → £43,234,000

• Employees

  -20.8%

  1,673 → 1,325

• Operating profit

  -99.7%

  £11,380,000 → £34,000

• Profit before tax

  -67.2%

  £16,647,000 → £5,455,000

• Wages

  -13.9%

  £63,248,000 → £54,455,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers